Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Neuroendocrine × Leucovorin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 179 Rectal Neoplasms 98 Colonic Neoplasms 73 Stomach Neoplasms 63 Pancreatic Neoplasms 51 Neoplasm Metastasis 46 Esophageal Neoplasms 32 Neoplasms 23 Lymphoma 21 Leukemia 21 Adenocarcinoma Of Esophagus 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Burkitt Lymphoma 16 Adenocarcinoma 15 Carcinoma, Hepatocellular 14 Cholangiocarcinoma 13 Biliary Tract Neoplasms 13 Gallbladder Neoplasms 8 Bile Duct Neoplasms 8 Lymphoma, Mantle-Cell 7 Colorectal Cancer Metastatic 6 Osteosarcoma 5 Lymphoma, Large B-Cell, Diffuse 5 Liver Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Dendritic Cell Sarcoma, Interdigitating 5 Breast Neoplasms 5 Sarcoma 4 Lymphoma, Non-Hodgkin 4 Gastrointestinal Neoplasms 4

Interventions

Everolimus 9 Cisplatin 7 Temozolomide 5 Bevacizumab 5 lutetium Lu 177 dotatate 4 Nivolumab 4 Etoposide 4 Carboplatin 4 Capecitabine 4 Irinotecan 3 sintilimab 2 pembrolizumab 2 dostarlimab 2 cabozantinib 2 azaspirane 2 avelumab 2 atezolizumab 2 Paclitaxel 2 Ipilimumab 2 Immunoglobulin G 2 IFL protocol 2 Fluorouracil 2 Fluorodeoxyglucose F18 2 Disulfides 2 zimberelimab 1 surufatinib 1 selinexor 1 pertuzumab 1 pasireotide 1 niraparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03837977 2024-12-30

NET02

The Christie NHS Foundation Trust

Phase 2 Completed

Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡